CDXS

Codexis Inc

CDXS.US codexis.com + Research + Basket
CIK 0001200375
Employees 146
Phone 650 421 8100
Fiscal year end December
IPO Apr 22, 2010
Address 200 Penobscot Drive, Redwood City, CA, United States, 94063
1.02
-0.06 (-5.56%)
USD · NASDAQ
52-week range
0.96
2.98
Trading at 3% of the 52-week range
Market Cap
118.27M
P/E Ratio
0.00
Forward P/E
149.25
Book Value
0.36
Div. Yield
N/A
% Institutions
73.92%
% Insiders
7.11%

1 Year

-52.6%

3 Year

-41.5%

10 Year

-78.1%
Description

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Actions

Add an action for CDXS.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Alison Moore Ph.D. President, CEO & Director 1967
Ms. Georgia L. Erbez CFO & Chief Business Officer 1967
Dr. Stefan Lutz Ph.D. Chief Scientific Officer NA
Mr. Britton Jimenez Senior Vice President of Sales & Marketing NA
Ms. Karen Frechou-Armijo Senior VP & Head of Human Resources NA
Mr. John Schiffhauer Senior Vice President of Intellectual Property NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Feb 24, 2026 Stefan Lutz N/A Sale 5.86K $1.13 $6.62K SEC
Feb 06, 2026 Alison Moore N/A Sale 3.83K $1.31 $5.01K SEC
Feb 06, 2026 Georgia Erbez N/A Sale 3.83K $1.31 $5.01K SEC
Feb 06, 2026 Stefan Lutz N/A Sale 2.49K $1.31 $3.26K SEC
Jan 07, 2026 Stefan Lutz N/A Sale 4.69K $1.70 $7.96K SEC
Oct 13, 2025 Alison Moore N/A Sale 6.24K $2.51 $15.66K SEC
Oct 13, 2025 Georgia Erbez N/A Sale 6.24K $2.50 $15.60K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 7.28M Jun 30, 2026 6.66% $0.00 3.64%
Nantahala Capital Management, LLC 7.25M Jun 30, 2026 6.63% $0.27 75.75%
Opaleye Management Inc 6.79M Jun 30, 2026 6.20% $1.39 0.00%
Aberdeen Group PLC 6.77M Jun 30, 2026 6.19% $0.02 -22.01%
Millennium Management LLC 5.55M Jun 30, 2026 5.07% $0.00 38.79%
Telemark Asset Management, LLC 3.85M Jun 30, 2026 3.52% $0.63 0.00%
Ameriprise Financial Inc 3.81M Jun 30, 2026 3.48% $0.00 12.03%
Vanguard Capital Management, LLC 3.62M Jun 30, 2026 3.31% $0.00 -1.40%
Assenagon Asset Management SA 2.56M Jun 30, 2026 2.34% $0.00 240.32%
Geode Capital Management, LLC 2.16M Jun 30, 2026 1.98% $0.00 14.69%
State Street Corp 1.76M Jun 30, 2026 1.61% $0.00 5.39%
D. E. Shaw & Co LP 1.34M Jun 30, 2026 1.23% $0.00 36.96%
Jacobs Levy Equity Management, Inc. 1.33M Jun 30, 2026 1.22% $0.01 22.26%
Vanguard Portfolio Management, LLC 1.31M Jun 30, 2026 1.20% $0.00 48.65%
AQR Capital Management LLC 845.43K Jun 30, 2026 0.77% $0.00 38.91%
Two Sigma Investments LLC 696.60K Jun 30, 2026 0.64% $0.00 187.90%
Northern Trust Corp 682.94K Jun 30, 2026 0.62% $0.00 3.93%
Franklin Templeton Inc 678.64K Jun 30, 2026 0.62% $0.00 -1.39%
Morgan Stanley - Brokerage Accounts 649.17K Jun 30, 2026 0.59% $0.00 37.29%
Vanguard Fiduciary Trust Co 581.06K Jun 30, 2026 0.53% $0.00 5.45%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 abrdn Healthcare Investors 7.01M 6.41% ▲ 0.00% Sep 30, 2026
2 abrdn Life Sciences Investors 3.79M 3.46% ▲ 0.00% Sep 30, 2026
3 Vanguard MStar Total Stk Mkt Idx Invest 3.08M 2.81% ▲ 0.00% Sep 30, 2026
4 iShares Russell 2000 ETF 2.47M 2.25% ▼ 0.41% Oct 29, 2026
5 Columbia Small Cap Value Discv A 2.08M 1.90% ▼ 22.34% Sep 30, 2026
6 Fidelity Small Cap Index 942.51K 0.86% ▲ 0.39% Jul 31, 2026
7 iShares Russell 2000 Growth ETF 813.48K 0.74% ▲ 0.25% Oct 29, 2026
8 iShares Biotechnology ETF 794.87K 0.73% ▼ 0.19% Oct 29, 2026
9 Vanguard Russell 2000 ETF 592.09K 0.54% ▲ 18.90% Sep 30, 2026
10 Putnam Small Cap Value A 532.70K 0.49% ▲ 0.00% Sep 30, 2026

Financial Highlights

▼
Market Cap: $118.27M
EBITDA: $-19.05M
PEG Ratio: $13.53
Book Value: $0.36
Earnings/Share: $-0.33
Profit Margin: -39.55%
Operating Margin: -75.29%
ROA (TTM): -11.74%
ROE (TTM): -69.36%
Revenue (TTM): $77.68M
Revenue/Share (TTM): $0.86
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -2.70%

Valuation Metrics

Enterprise Value: $135.94M
Trailing P/E: 0.00
Forward P/E: 149.25

Shares Statistics

Shares Outstanding: 109.51M
Shares Float: 82.30M
% Insiders: 7.11%
% Institutions: 73.92%
Shares Short: 4.95M
Shares Short (Prior Month): 4.84M
Short Ratio: 5.67
Short % Float: 4.58%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$70.39M
Cost of Goods Sold
adjust
$-9.34M
Gross Profit
subtotal
$61.05M
SG&A
adjust
$-47.07M
R&D
adjust
$-52.31M
Operating Income
subtotal
$-38.33M
Other / Non-Operating Items
adjust
$-5.64M
Net Income
subtotal
$-43.97M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CDXS.US!